The Netherlands compounding pharmacies market involves the preparation of customized medications as per the needs and medical requirements of an individual patient. The compounded drugs are formulated to fulfill unmet medical needs and help patients having allergies or sensitivities to specific ingredients in commercially available drugs. Compounding pharmacies provide specialized drug formulations like capsules, creams, oral liquids, and suppositories. This helps deliver the right dose and ensures optimal therapeutic outcomes. The demand for compounded drugs in the Netherlands is rising due to growing geriatric population base with complex medical requirements. Moreover, compounding pharmacies play an important role in drug shortages by preparing alternative formulations.

The Global Netherlands Compounding Pharmacies Market is estimated to be valued at US$ 599.62 Mn in 2024 and is expected to exhibit a CAGR of 6.5% over the forecast period 2024 to 2030.


Key Takeaways

Key players operating in the Netherlands compounding pharmacies are GE Healthcare, Invacare Corporation, Inogen, IUC Medical (Smiths Medical), HERSILL S.L., Fisher & Paykel Healthcare Limited, Philips Respironics, Inc., DeVilbiss Healthcare, Tecno-Gaz Industries, Allied Healthcare Products, Inc., Teleflex Incorporated, Chart Industries, ResMedDrägerwerk AG & Co. KGaALinde, CAIRE. The key players are focusing on expanding their product portfolios and geographic reach through strategic collaborations and acquisitions.

Some key opportunities in the Netherlands compounding pharmacies market include strong demand for customized drugs, drug shortages leading to increased compounding activities, and rising adoption of advanced compounding technologies.

The global expansion activities of major compounding pharmacies are expected to boost the availability of compounded drugs in the Netherlands. Favorable reimbursement policies are also facilitating market growth by improving affordability and access to compounded drugs.

Market drivers

The demand for compounded medications in the Netherlands is driven by the increasing geriatric population susceptible to chronic illnesses requiring specialized drug formulations. As per estimates, over 20% of the Dutch population will be aged 65 years and above by 2030. This aging demographic is a high consumer of customized medications prepared by compounding pharmacies. Hence, it is considered as a major market driver.

PEST Analysis

Political: The Dutch government has been encouraging generics uptake by patients to curb the country's healthcare expenditure which is supporting the growth of compounding pharmacies in Netherlands.

Economic: Rising healthcare costs in Netherlands has been triggering demand for affordable compounding pharmacy medications made from bulk active pharmaceutical ingredients.

Social: Growing patient awareness about compounding pharmacy medications and their cost-effectiveness is boosting their uptake in Netherlands.

Technological: Adoption of advanced compounding equipment and workflow management solutions by pharmacies is helping increase production efficiency and precision while maintaining sterility. Automation is also helping reduce errors and streamline operations.

The Netherlands Compounding Pharmacies Market Size is concentrated mainly in the western region including provinces like North Holland, South Holland, Utrecht and Zeeland in terms of value. The northern region comprising provinces like Groningen, Friesland, Drenthe is also gaining market share steadily owing to increasing elderly population seeking customized medications.

The southern region including North Brabant and Limburg provinces is witnessing fastest growth in the Netherlands compounding pharmacies market driven by rapidly developing pharmaceutical hubs in Eindhoven and Maastricht. Rising biotech companies outsourcing their compounding needs coupled with improving healthcare infrastructure are fueling market revenues from this region.

Get more insights on- Netherlands Compounding Pharmacies Market